Recombinant Anti-Human A human cancer antigen Antibody (Fc glycosylation) (CAT#: Gly-079LC)
This product is a humanized monoclonal antibody with N-glycosylation site in the Fc region. The antibody NRX451 with enhanced ADCC specifically binds 40 kilodalton glycoprotein antigen expressed on a large array of carcinomas and can be potentially used in the treatment of cancer.
Specific Inquiry
Glyco-engineering
- Glycosylation site
- Fc region
- Glycosylation Type
- N-glycosylation
- Activity
- Enhanced ADCC
Specifications
- Target
- a human cancer antigen
- Host Species
- Human
- Derivation
- Humanized
- Type
- Humanized antibody
- Specificity
- Human
- Clone
- NRX451
- Applications
- ELISA
Target
- Alternative Names
- a human cancer antigen
- Related Disease
- Cancer
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for Gly-079LC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.